Navigation Links
VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Merck's Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
Date:11/17/2010

NEW YORK, Nov. 17, 2010 /PRNewswire/ -- See video from Merck and Co., Inc at:

http://www.thenewsmarket.com/Releases/StoryDetailPage.aspx?GUID=e64f9345-a404-4b7d-8323-6aa1e1650bc9&alertid=95ea2637-0ea8-4ec1-a5a8-f8083ece9012&bhcp=1#    

Researchers today presented results from the Phase III DEFINE (Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib) study with Merck's investigational CETP inhibitor, anacetrapib. In the trial of 1,623 patients with coronary heart disease (CHD) or CHD risk equivalents, anacetrapib showed no significant differences from placebo in the primary safety measures studied. There were no significant differences in mean changes in blood pressure between the anacetrapib and placebo treatment groups, nor were there any significant differences in serum electrolytes or aldosterone levels. During the 76-week treatment phase, the pre-specified adjudicated cardiovascular endpoint (defined as cardiovascular death, myocardial infarction, unstable angina or stroke) occurred in 16 anacetrapib-treated patients (2.0 percent) compared with 21 placebo-treated patients (2.6 percent) (p=0.40). At 24 weeks, anacetrapib decreased LDL-C by 40 percent (from 81 to 45 mg/dl vs. 82 to 77 mg/dl for placebo, p<0.001) and increased HDL-C by 138 percent (from 40 to 101 mg/dl vs. 40 to 46 mg/dl for placebo, p<0.001) in patients already treated with a statin and at guideline-recommended LDL-C goal. The DEFINE data were presented today at the American Heart Association Scientific Sessions and published concurrently online in the New England Journal of Medicine. Available content includes soundbites and b-roll.

About thenewsmarket.com

thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia con
'/>"/>

SOURCE thenewsmarket.com
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. VIDEO from International Osteoporosis Foundation available on thenewsmarket.com: IOF Focuses on WHO Fracture Risk Assessment Tool for International Discussions
2. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
3. VIDEO From thenewsmarket.com and Lundbeck: Lundbeck Continues Strong Growth in Third Quarter
4. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
5. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
6. VIDEO From thenewsmarket.com and AstraZeneca: AstraZeneca Announces Third Quarter and Nine Months Results 2010
7. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
8. Generex Reschedules Live Video Webcast
9. Aircraft Medical Launches Worlds First Low Cost Video Laryngoscope
10. New Manhattan Research Report Explores the Growing Consumer Demand for Online Health Video and How Pharma Marketers Can Leverage this Format
11. New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2013)... Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, announced that Oracle Investment Management, Jack ... certain other investors have exercised warrants to purchase 12.1 ... price of $1.46 per share. The ... transaction that closed on May 13, 2013. With the ...
(Date:12/19/2013)... -- Covance Inc. (NYSE: CVD ) said today ... of up to $100 million of its outstanding common ... upon business and market conditions and other factors.  The ... and may be made through a variety of methods ... and 10b5-1 plans. Covance, with headquarters in ...
(Date:12/19/2013)... 2013  Today BioSpace , the leading life ... Genetown™ Hotbed Campaign , marking the campaign,s fifteenth edition. ... The Genetown Hotbed campaign launches each December, featuring leading ... and parts of New England. The area continues to ... than 15 percent of all jobs on BioSpace.com located ...
Breaking Medicine Technology:Vermillion Completes $17.6 Million Warrant Exercise 2Vermillion Completes $17.6 Million Warrant Exercise 3Covance Board Authorizes $100 Million Stock Buyback 2BioSpace Map Spotlights Massachusetts' Life Science Employers 2
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
(Date:12/19/2013)... Myers Beach, Florida (PRWEB) December 19, 2013 ... on Fort Myers Beach, Florida, made a charitable ... non-profit organization that funds breast care services for low-income, ... County. On Monday, December 2, two checks totaling $1,270.00, ... breast screenings and/or diagnostic testing for eligible women and ...
(Date:12/19/2013)... The new “sleepiness prevention tips” article on the ... stay alert effectively. This article is actually ideal for ... sleepiness and have a good night’s sleep naturally. At ... to take a quick nap in order to dispel ... shows that a short, 10-minute nap makes people more ...
(Date:12/19/2013)... 2013 Skmen.com, a reliable online fashion shop ... sale. Customers from around the world can now order ... , The responsible company has updated its website; it is ... Each of its products are carefully made from the most ... company's website are easy and secure. , “We are excited ...
(Date:12/19/2013)... 2013 The Workgroup for Electronic ... use of Health IT to improve healthcare information ... & Medicaid Services (CMS) and other public and ... Initiative. The goal of this initiative is to ... industry stakeholders including healthcare providers, payers, clearinghouses and ...
(Date:12/19/2013)... As healthcare costs continue to balloon, a new ... savings: nurse home visits. For every $1 spent on ... healthcare costs. The home visiting program more than paid ... life. , In addition to saving on emergency room ... families had lower rates of maternal anxiety and safer ...
Breaking Medicine News(10 mins):Health News:Pink Shell Beach Resort & Marina Benefits Partners for Breast Cancer Care 2Health News:“Sleepiness Prevention Tips,” A New Article On Vkool.com, Teaches People How to Fight Sleepiness Naturally - V-kool 2Health News:Men’s Outerwear Sale At Reliable Online Shop Skmen.com 2Health News:WEDI, CMS and Industry Partners to Launch ICD-10 Implementation Success Initiative 2Health News:WEDI, CMS and Industry Partners to Launch ICD-10 Implementation Success Initiative 3Health News:Saving dollars while helping babies 2
... Former CBS Early Show Anchor, Jane Clayson Will Host Podcast, ... moms on the go, a new series of podcasts launched ... baby health, and,nutrition, as well as answers to the questions ... You -- Champion for Babies is a one-on-one interview,series hosted ...
... healthcare professionals from across Pennsylvania with substantial ... HARRISBURG, Pa., Sept. 11 The Pennsylvania,Patient Safety ... of infection control experts to help implement Act ... by Governor Ed Rendell in July to help ...
... PCMA: Time to Require E-Prescribing in Medicare, ... finds,dangerous drug side effects and deaths - particularly ... underscores the urgency for Congress to act,now to ... Management Association (PCMA) said today., "This study ...
... CHICAGO, Ill. The nuclear power industry is riding the ... of a low-carbon solution to our growing energy needs. ... role nuclear can realistically play, it is bound by ... still predominantly shaped by the marketplace. , Veteran ...
... prostate cancer among men taking the drug finasteride is ... not by the development of more high-grade cancers, according ... Journal of the National Cancer Institute . , ... long-term randomized trial of a possible drug to prevent ...
... at least some education beyond high school is associated with ... education levels were strongly associated with decreased cancer mortality among ... mortality for all groups was greatest between those with 12 ... 12 years. , Previous studies have found that death rates ...
Cached Medicine News:Health News:March of Dimes, Experts for Moms and Babies, Launches Podcast 2Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 2Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 3Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 4Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 5Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 6Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 7Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 8Health News:Patient Safety Authority Board of Directors Names Infection Advisory Panel 9Health News:New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest 2Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Finasteride unlikely to induce high grade prostate cancers 2Health News:Finasteride unlikely to induce high grade prostate cancers 3Health News:Study links education to risk of cancer death 2Health News:Study links education to risk of cancer death 3
Ideal for use with low volume samples on the Biomek robotic pipetting systems, the ART 20R provides guaranteed protection for your expensive workstation....
... false signals and contamination caused by ... Barrier Tips offer performance and economy ... (PCR(a)), radioactive isotopes, tissue culture fluids, ... , ,Promega Barrier Tips are made ...
... AvantGard Low Binding 0.5l - 10l Eppendorf ... binding technology that significantly reduces the amount of ... other filter tips are advertised as low retention, ... adhering to the pipet tip. However, AvantGard also ...
10 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
Medicine Products: